Document is current
Any future updates will be listed below
-
Authors
Juntunen, Miia https://orcid.org/0000-0001-5282-4376
Heinonen, Sini
Huhtala, Heini
Rissanen, Aila
Kaprio, Jaakko
Kuismanen, Kirsi
Pietiläinen, Kirsi H.
Miettinen, Susanna
Patrikoski, Mimmi
-
Funding
Funding for this research was provided by:
Suomen Kulttuurirahasto (00190409)
Academy of Finland (326588, 311084, 272376, 314383, 266286, 312073)
Business Finland
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital
Tampere University Graduate School for Medicine and Life Sciences
Helsinki University Hospital funds
Finnish Diabetes Research Foundation
Orion Foundation
Paulo Foundation
Finnish Medical Foundation
Maud Kuistila Foundation
Gyllenberg Foundation
Sigrid Juséliuksen Säätiö
Novo Nordisk Foundation (NNF17OC0027232, NNF10OC1013354)
University of Helsinki and the Government Research Funds through Helsinki University Hospital
- License Information
-
More Information
Article History
Received: 23 March 2021
Accepted: 11 September 2021
First Online: 26 September 2021
Declarations
:
: The MZ twin study was conducted in accordance with the Ethics Committee of Hospital District of Helsinki and Uusimaa, Helsinki, Finland (270/13/03/01/2008), and HUVEC collection for angiogenesis potential assay was conducted in accordance with the Ethics Committee of the Pirkanmaa Hospital District, Tampere (R13019). Written informed consent was obtained from all participants and donors.
: Not applicable.
: The authors declare no competing interests.
